This CFTR potentiator was tested on CF patients bearing at least one G551D-CFTR allele, and gave very promising results on major clinical parameters (notably, percentage of predicted forced expiratory volume in 1 second: FEV-1), with significant improvement in lung function [14–16]. The gene discussed is CFTR; the disease is cystic fibrosis.